Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment
A cell-penetrating, anti-inflammatory peptide developed by Jack Hawiger, Louise B. McGavock Chair and Distinguished Professor of Medicine, and licensed to biopharmaceutical company…
